A Study of BL-B01D1 With or Without PD-1 Monoclonal Antibody in Patients With High-Risk Locally Advanced Nasopharyngeal Carcinoma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This Phase II study is a clinical trial exploring the efficacy and safety of BL‐B01D1with or without PD‐1 monoclonal antibody in patients with high‐risk locally advancednasopharyngeal carcinoma.
Epistemonikos ID: 84378d04c47543d79a90a54d82f15b2f8fc7c67b
First added on: Sep 01, 2026